1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INCYTE CORP.
Incyte Corp. XNAS: INCY

Incyte Live Stock Price Today, Share Analysis and Chart

Strong Performer
about

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheuma...

Read More
104.54 -1.79 (-1.68%)
New 52W High in past week
718.2K
XNAS Volume

XNAS 13 Jan, 2026 2:09 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The latest board meeting for Incyte took place on 12 Jan 2026, for the purpose of 44th Annual J. P. Morgan Healthcare Conference See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Affordable Valuation
52.7 / 100
Momentum Score
Technically Bullish
71.4 / 100
Strong Performer These stock companies have strong financials and are affordably priced. They also score high in quality and technical metrics which make them popular with investors View Similar Embed DVM
Analyst Price Target
102
1Yr Price target downside is -2%
21 analysts

25

S

6

W

6

O

0

T

SWOT Analysis

Incyte Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..